These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38469266)

  • 1. The concern about noradrenergic and antimuscarinic agents for OSA.
    Wang D; Chen R; Zhang N
    Sleep Biol Rhythms; 2022 Apr; 20(2):319-320. PubMed ID: 38469266
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials.
    Zha S; Yang H; Yue F; Zhang Q; Hu K
    Sleep Med Rev; 2022 Aug; 64():101649. PubMed ID: 35709641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity.
    Thomson LDJ; Landry SA; Joosten SA; Mann DL; Wong AM; Cheung T; Adam M; Beatty CJ; Hamilton GS; Edwards BA
    Physiol Rep; 2022 Aug; 10(16):e15440. PubMed ID: 36029192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
    Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
    J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
    Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
    J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
    Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
    Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
    [No Abstract]   [Full Text] [Related]  

  • 7. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
    Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
    Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials.
    Lee YC; Lu CT; Chuang LP; Lee LA; Fang TJ; Cheng WN; Li HY
    Sleep Med Rev; 2023 Aug; 70():101809. PubMed ID: 37423095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic activity of the antimuscarinic antiparkinsonian agents.
    Modell JG; Tandon R; Beresford TP
    J Clin Psychopharmacol; 1989 Oct; 9(5):347-51. PubMed ID: 2551932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
    Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
    Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional case-control study of the relationships between pharyngeal compliance and heart rate variability indices in childhood obstructive sleep apnoea.
    Bokov P; Mauvais FX; Madani A; Matrot B; Lecendreux M; Delanoë C; Konofal E; Gallego J; Delclaux C
    J Sleep Res; 2021 Oct; 30(5):e13337. PubMed ID: 33880823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Kay GG; Abou-Donia MB; Messer WS; Murphy DG; Tsao JW; Ouslander JG
    J Am Geriatr Soc; 2005 Dec; 53(12):2195-201. PubMed ID: 16398909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of pontine A7 noradrenergic neurons is suppressed during REM sleep.
    Fenik VB; Rukhadze I
    J Appl Physiol (1985); 2022 Jul; 133(1):130-143. PubMed ID: 35616303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacological and sex-specific effects of antimuscarinic agents at the hypoglossal motor nucleus in vivo in rats.
    Niakani S; Liu H; Liu WY; Horner RL
    Sci Rep; 2022 Sep; 12(1):14896. PubMed ID: 36050440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial.
    Taranto-Montemurro L; Sands S; Azarbarzin A; Calianese N; Vena D; Hess L; Kim SW; White DP; Wellman A
    Respirology; 2021 May; 26(5):485-492. PubMed ID: 33491327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
    Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
    J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies.
    Horner RL
    Expert Opin Ther Targets; 2023; 27(7):609-626. PubMed ID: 37494064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
    Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
    Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation.
    Perger E; Castiglioni P; Faini A; Soranna D; Zambon A; Rosa D; Vicini S; Meriggi P; Pini L; Baratto C; Caravita S; Azarbarzin A; Parati G; Lombardi C
    Sci Rep; 2023 Feb; 13(1):3178. PubMed ID: 36823241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.